ReviewAmerican journal of nuclear medicine and molecular imaging2018

Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine.

Rubel Chakravarty et al.PubMed ↗Full text ↗

No numbers read from the abstract.